I received PhD in Biostatistics at University of North Carolina at Chapel Hill in 2013. I worked at the department of biostatistics, University of Texas MD Anderson Cancer Center 2016-2021 as an assistant professor. I am currently working at the Biohealth Data Science at Yonsei University, Seoul, Korea. ✉️

Professional Appointments (Associate Professor @ Yonsei University)

2025-Current, Biohealth Data Science, Yonsei University (primary)

2022-Current, Department of Health Informatics and Biostatistics, Graduate School of Public Health, Yonsei University

2022-Current, Department of Biostatistics and Computing, Yonsei University

2022-Current, Department of Public Health, Yonsei University

경력

• 2025.03-현재 연세대학교 융합보건의료대학원 바이오헬스 데이터과학 부교수 (전공지도교수)

• 2025.03-현재  연세대학교 보건대학원 보건정보통계학과 부교수 (전공지도교수)

• 2022.03-2025.02 연세대학교 보건대학원 보건정보통계학과 조교수 (전공지도교수)

• 2016.05-2022.02 MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences 조교수

• 2016.05-2022.02 텍사스주립대 MD Anderson Cancer Center 조교수

• 2013.10-2016.04 텍사스주립대 MD Anderson Cancer Center 박사후 연구원

수상

• 2012.08 David P. Byar Young Investigator Award, Biometrics section, American Statistical Association

• 2013.08 ASA Student Paper Award, Section on Statistical Learning and Data Mining, American Statistical Association

학술활동

• 2025.08-2028.08 한국정보산업협회 바이오빅데이터융합위원회 위원장

• 2025.06-2027.05 국민건강보험공단 본부 자문위원

• 2025.06-2027.05 한국데이터산업진흥원 자문위원

• 2022.03-현재 연세대학교 보건정책 및 관리연구소 보건정보관리부 (부장)

• 2023.04-2023.12 건강보험심사평가원 객원연구위원

• 2022.02-현재 연세대학교 IRB 통계위원

• 2019.01-2022.02 MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences, Quantitative Sciences curriculum committee 자문위원

• 2019.01-2022.02 MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences, Faculty Academic Review Committee, 자문위원

• 2019.01-2022.02 University of Texas MD Anderson Cancer Center, Department of Biostatistics, Faculty Search committee, 자문위원

• 2019.01-2022.02 University of Texas MD Anderson Cancer Center, Institutional Animal Care and Use Committee, 자문위원

학회활동

• 2025 - 현재 생물통계연구회 총무

• 2025-  현재 한국보건정보통계학회 교육이사

연구과제 수행실적

• 2022.09-2027.02 한국연구재단 중견연구 연구책임자 (과제명: 다층 데이터를 위한 그래프 이론 기반 융합적 통계 방법론 연구)

• 2025.06-2025.10 식품의약품안전처 연구개발사업 연구책임자 (과제명: 마약류통합관리시스템을 활용한 의료용 마약류 수요 모니터링 체계 구축 방안 마련)

• 2025.05-2027.04 한국의학연구소 공동연구지원사업 책임연구원 (과제명: 건강검진 지침과 효과 연구)

• 2018.09-2022.02 디렉터, Biostatistics and Bioinformatics, Leukemia and Lymphoma Society, 미국

• 2019.10-2022.02 디렉터, Data Science, 미국국립보건원 (University of Texas PDX Development and Trial Center)

• 2018.07-2021.06 연구책임자, 미국국립보건원 (Title: Proteomic-based integrated subject-specific networks in cancer)

• 2021.02-2022.02 연구책임자, 미국국립보건원 (Title: Bayesian Network-Based Integrative Genomics Methods for Precision Medicine)

• 2016.05-2017.12 공동연구자, 미국국립보건원 (Title: Risk Prediction for ER-Negative Breast Cancer Recurrence)

• 2016.05-2020.11 공동연구자, 미국국립보건원 (Title: Graph-based Bayesian Analysis of Genomics and Proteomics Data)

• 2016.08-2020.08 공동연구자, Cancer Prevention & Research Institute of Texas (Title: Acute Myeloid Leukemia in the Immunosuppressed Microenvironment)

• 2016.08-2021.08 공동연구자, Cancer Prevention & Research Institute of Texas (Title: A Randomized Clinical Trial Platform)

• 2017.09-2021.08 공동연구자, 미국국립보건원 (Title: Cytoplasmic cyclin E is an early event for progression invasive breast cancer)

• 2018.08-2022.02 공동연구자, Cancer Prevention & Research Institute of Texas (Title: Overcoming PARP inhibitor resistance in pa- tients with breast cancer who have germline BRCA mutations)

• 2020.08-2022.02 공동연구자, Cancer Prevention & Research Institute of Texas, 미국 (Title: Targeted Proteolysis of Glucocorticoid Receptor (GR) as a Therapeutic Strategy to Enhance Anti-Tumor Immunity)

• 2019.10-2022.09 공동연구자, 미국국립보건원 (Title: Mechanisms and Vulnerabilities of SWI/SNF chromatin remod- eling complex mutant lung cancer)

• 2016.08-2022.02 공동연구자, 미국국립보건원 (Title: SPORE: Targeting Lung Cancer Vulnerabilities)

• 2018.08-2022.08 공동연구자, Cancer Prevention & Research Institute of Texas, 미국 (Title: Rational Combination Treatment Options to Reverse Resistance in Hormone Receptor Positive Breast Cancer Refractory to Standard Therapy)

• 2019.09-2022.02 공동연구자, The University of Texas MD Anderson Cancer Center (Title: Therapeutic Targeting of DKK3 in Pancreatic Cancer and Response to Chemotherapy)

• 2021.07-2022.02 공동연구자, 미국국립보건원 (Title: RNase H2 is a novel therapeutic target in triple negative breast cancer)

• 2021.07-2022.02 공동연구자, Boehringer Ingelheim Pharm Inc. (Title: Targeting ROR1 Overexpressing Tumors with NBE-002)

• 2016.09-2022.02 Biostatistician, Biostatistics Resource Group, 텍사스주립대 MD Anderson Cancer Center

• 2016.09-2017.08 Biostatistician, Department of Breast Surgical Oncology, 텍사스주립대 MD Anderson Cancer Center